SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Raising financing through strategic timing
16 references·0 citing·54 second hop
Raising financing through strategic timing (2017)Raising financing through strategic timingWhere is Silicon Valley? (2015)Where is Silicon Valley?Radical innovation from the confluence of technologies: Innovation management strategies for the emerging nanobiotechnology industry (2013)Radical innovation from the c…Intellectual Property Rights and Innovation: Evidence from the Human Genome (2013)Intellectual Property Rights …Organizing Ecologies of Complex Innovation (2011)Organizing Ecologies of Compl…Case study research: design and methods (2011)Case study research: design a…The importance of new companies for drug discovery: origins of a decade of new drugs (2010)The importance of new compani…The evolution of science-based business: innovating how we innovate (2010)The evolution of science-base…On firm ground: IP protection of therapeutic nanoparticles (2010)On firm ground: IP protection…Handbook of the Economics of Innovation (2010)Handbook of the Economics of …Entrepreneurship and the construction of value in biotechnology (2010)Entrepreneurship and the cons…Open access chemical and clinical probes to support drug discovery (2009)Open access chemical and clin…Radical innovation through internal corporate venturing: Degussa's commercialization of nanomaterials (2008)Radical innovation through in…PATENTS AS QUALITY SIGNALS FOR ENTREPRENEURIAL VENTURES. (2008)PATENTS AS QUALITY SIGNALS FO…Commercializing generic technology: The case of advanced materials ventures (2006)Commercializing generic techn…Biotech‐Pharmaceutical Alliances as a Signal of Asset and Firm Quality (2005)Biotech‐Pharmaceutical Allian…Case Study Research: Design and Methods (1984)Case Study Research: Design a…Innovation and small firms (1991)The Promise of Entrepreneurship as a Field of Research (2000)Big Data: New Tricks for Econometrics (2014)University Innovation and the Professor's Privilege (2018)The State of American Entrepreneurship: New Estimates of the Quantity and Quality of Entrepreneurship for 32 US States, 1988–2014 (2020)AI adoption in America: Who, what, and where (2024)Regional advantage: culture and competition in Silicon Valley and Route 128 (1994)Lessons from 60 years of pharmaceutical innovation (2009)The New Argonauts. Regional Advantage in a Global Economy (2009)The Role of Public-Sector Research in the Discovery of Drugs and Vaccines (2011)Orphan drug development: an economically viable strategy for biopharma R&D (2012)Asymmetric Growth and Institutions in an Interdependent World (2017)MAKING FAST STRATEGIC DECISIONS IN HIGH-VELOCITY ENVIRONMENTS. (1989)CASE Tools as Organizational Change: Investigating Incremental and Radical Changes in Systems Development (1993)Research Design: Qualitative, Quantitative, and Mixed Methods Approaches (1994)Knowledge Specialization, Organizational Coupling, and the Boundaries of the Firm: Why Do Firms Know More than They Make? (2001)Case Study Research (2004)Research Design: Qualitative, Quantitative, and Mixed Methods Approaches (2009)The Problem of Social Cost (1960)Endogenous Technological Change (1989)Econometric Analysis of Cross Section and Panel Data (2001)Defining Elements of Value in Health Care—A Health Economics Approach: An ISPOR Special Task Force Report [3] (2018)A Toolkit of Policies to Promote Innovation (2019)Digital Economics (2019)The reflective practitioner: How professionals think in action (1984)The Reflective Practitioner: How Professionals Think in Action (1985)Capitalism, Socialism and Democracy (1997)The Rise of Platform Ecosystems (2013)Governance Practices in Platform Ecosystems: Navigating Tensions Between Cocreated Value and Governance Costs (2017)Why Do Companies Pursue Collaborative Circular Oriented Innovation? (2019)Economic Welfare and the Allocation of Resources for Invention (1962)Job Market Signaling (1973)Foundations of social theory (1990)Standing out from the crowd: the visibility-enhancing effects of IPO-related signals on alliance formation by entrepreneurial firms (2007)Cross-border venture capital investments in Asia: Selection and exit performance (2011)Unmixed signals: How reputation and status affect alliance formation (2013)ON THE EFFICIENCY OF COMPETITIVE STOCK MARKETS WHERE TRADES HAVE DIVERSE INFORMATION (1976)Informational Asymmetries, Financial Structure, and Financial Intermediation (1977)Joint ventures: Theoretical and empirical perspectives (1988)Productivity in pharmaceutical–biotechnology R&D: the role of experience and alliances (2005)Valuing R&D Projects in a Portfolio: Evidence from the Pharmaceutical Industry (2007)Charity as a Substitute for Reputation: Evidence from an Online Marketplace (2012)Dynamic capabilities and strategic management (1997)Dynamic capabilities: what are they? (2000)Business-Model Innovation: General Purpose Technologies and their Implications for Industry Structure (2009)Ideas for rent: an overview of markets for technology (2010)Technological discontinuities and the challenge for incumbent firms: Destruction, disruption or creative accumulation? (2013)Diffusion of Innovations 1 (2019)Mixed Methods Research: A Research Paradigm Whose Time Has Come (2004)Qualitative research: Methods in the social sciences (2006)Document Analysis as a Qualitative Research Method (2009)Innovation and Productivity: An Update (2013)R&D and Productivity: Estimating Endogenous Productivity (2013)PUBLIC R&D POLICIES AND PRIVATE R&D INVESTMENT: A SURVEY OF THE EMPIRICAL EVIDENCE (2014)
this work references cited by second hop

References

  • 1984Case Study Research: Design and Methods81,948 cited
  • 2011Case study research: design and methods21,763 cited
  • 2010Handbook of the Economics of Innovation902 cited
  • 2013Intellectual Property Rights and Innovation: Evidence from the Human Genome508 cited
  • 2010The importance of new companies for drug discovery: origins of a decade of new drugs344 cited
  • 2008PATENTS AS QUALITY SIGNALS FOR ENTREPRENEURIAL VENTURES.274 cited
  • 2011Organizing Ecologies of Complex Innovation266 cited
  • 2006Commercializing generic technology: The case of advanced materials ventures263 cited
  • 2015Where is Silicon Valley?213 cited
  • 2005Biotech‐Pharmaceutical Alliances as a Signal of Asset and Firm Quality173 cited
  • 2010The evolution of science-based business: innovating how we innovate151 cited
  • 2009Open access chemical and clinical probes to support drug discovery130 cited
  • 2010Entrepreneurship and the construction of value in biotechnology92 cited
  • 2010On firm ground: IP protection of therapeutic nanoparticles84 cited
  • 2013Radical innovation from the confluence of technologies: Innovation management strategies for the emerging nanobiotechnology industry

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

75 cited
  • 2008Radical innovation through internal corporate venturing: Degussa's commercialization of nanomaterials71 cited
  • Cited by

    No citing works inside the corpus for this window.